Overview

A Study to Characterize Diclofenac's Plasma and Knee Exposure After Application of Diclofenac Gel to the Knee of Subjects With Osteoarthritis That Have a Scheduled Arthroplasty

Status:
Completed

Trial end date:
2019-03-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the exposure of diclofenac in the plasma and in the knee joint following topical administration of DDEA gel 4 gram (g) applied twice daily for 7 days.

Phase:

Phase 1

Details

Lead Sponsor:

GlaxoSmithKline

Treatments:

Diclofenac